AI Generated
Apr 30, 2026, 12:45
Chokri Ben Lamine: Methemoglobinemia in Hematology – Causes, Diagnosis, Antidote
Chokri Ben Lamine, Assistant consultant at King Faisal Specialist Hospital and Research Center, shared a post on X:
“Methemoglobinemia in Hematology – Causes, Dx, Antidote
What is it?
Hb Fe²⁺ to Fe³⁺ leading to cannot carry O₂
Resulting in functional anemia and tissue hypoxia
Common causes in Hematology
- Dapsone (very common in PCP prophylaxis)
- Trimethoprim-sulfamethoxazole (rare)
- Benzocaine / lidocaine
- Nitric oxide
- Rasburicase (esp. G6PD)
- Primaquine
- Nitrates / nitrites
High risk:
- G6PD deficiency
- Renal failure
- High-dose or prolonged exposure
Clinical clues
- Dyspnea, fatigue
- Cyanosis not improving with O₂
- Headache, confusion
- Severe: arrhythmia, coma
Diagnosis
- ABG: normal PaO₂
- Pulse ox approximately 85% (fixed, not improving)
- Co-oximetry elevated reveals metHb % (confirm)
‘Saturation gap’ is key clue
Severity guide
- less than 10% – often asymptomatic
- 10–20% – cyanosis
- 20–50% – symptoms (dyspnea, fatigue)
- more than 50% – life-threatening
Treatment
1. STOP offending drug (e.g., Dapsone)
2.Methylene blue
- Dose: 1–2 mg/kg IV over 5 min
- Repeat in 1 hr if needed
Requires NADPH
- Avoid in G6PD deficiency (risk hemolysis)
If G6PD deficiency / refractory
- Vitamin C (ascorbic acid) high dose
- Exchange transfusion (severe)
- Hyperbaric O₂ (rare cases)
Monitoring
- Serial metHb levels
- Clinical response (O₂ sat improves)
- Watch for rebound (esp. dapsone long half-life)
Hematology pearl
- Dapsone – delayed and recurrent methemoglobinemia
- May need repeated treatment
Take-home
- Cyanosis and normal PaO₂ – think metHb
- Dapsone is the primary culprit in hematology patients
- Treat fast with methylene blue (unless G6PD).”
Other posts featuring Chokri Ben Lamine on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering